Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Schizophrenia Research
|
January 17, 1997
The Dose Reduction in Schizophrenia (DORIS) Study: a final report
J Hirschowitz, R Hitzemann, K Piscani, et al.
Schizophrenia Research
|
August 1, 1993
Early response to haloperidol treatment in chronic schizophrenia
R G Stern, R S Kahn, P D Harvey, et al.
Psychiatry Research
|
February 1, 1993
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia
M Davidson, R S Kahn, R G Stern, et al.
Biological Psychiatry
|
October 15, 1996
Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale
P D Harvey, M Davidson, L White, et al.
The American Journal of Psychiatry
|
June 1, 1996
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings
R S Keefe, E Frescka, S H Apter, et al.
Psychiatry Research
|
July 1, 1989
Lithium antagonism of ethanol-induced intoxication: relationship to intracellular lithium levels
J Hirschowitz, R Hitzemann, B Kovasznay, et al.
Psychiatry Research
|
February 1, 1992
Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects
R S Kahn, M Davidson, J Hirschowitz, et al.
Pharmaceutical Research
|
April 1, 1990
Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients
M G Choc, F Hsuan, G Honigfeld, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Schizophrenia Research
|
January 17, 1997
The Dose Reduction in Schizophrenia (DORIS) Study: a final report
J Hirschowitz, R Hitzemann, K Piscani, et al.
Schizophrenia Research
|
August 1, 1993
Early response to haloperidol treatment in chronic schizophrenia
R G Stern, R S Kahn, P D Harvey, et al.
Psychiatry Research
|
February 1, 1993
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia
M Davidson, R S Kahn, R G Stern, et al.
Biological Psychiatry
|
October 15, 1996
Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale
P D Harvey, M Davidson, L White, et al.
The American Journal of Psychiatry
|
June 1, 1996
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings
R S Keefe, E Frescka, S H Apter, et al.
Psychiatry Research
|
July 1, 1989
Lithium antagonism of ethanol-induced intoxication: relationship to intracellular lithium levels
J Hirschowitz, R Hitzemann, B Kovasznay, et al.
Psychiatry Research
|
February 1, 1992
Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects
R S Kahn, M Davidson, J Hirschowitz, et al.
Pharmaceutical Research
|
April 1, 1990
Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients
M G Choc, F Hsuan, G Honigfeld, et al.
Page
of 6